Phytopharm increases cash burn on Cogane


Revenue was principally generated from agreements with Unilever in respect of the development of Hoodia extract, Schering-Plough in respect of sales of the veterinary product Phytopica and from the sale of raw materials from inventory.
Development costs fell to 3.91m from 4.25m, reflecting reduced expenditure on the Hoodia extract programmes following termination arrangements with Unilever, offset by the increase in expenditure incurred on Cogane studies.

Read »

Swai Fish
Omega XL
Black Beans
Dijon Mustard
Pinto Beans
Bento Box

phentermine how weight loss fast
Side Effects of Phentermine

learn spanish app ipad apps for kids swift programming tutorial

Phytopharm increases cash burn on Cogane